1-Panel Urine Test:

FDA Cleared

Item: DMT-114

Quantity Price Each
1 to 9 $1.95
10 to 24 $1.60
25 to 99 $1.25
100 and up $.95

- In Stock -

Order Online

Panel Target Compound Cutoff Level
MTD Methadone 300 ng/mL
MTD Panel: Specifications

Specificity - MTD Drug Test Panel

The following compounds are detected positive in urine by the MTD One Step Methadone Drug Test at 5 minutes. Cutoff represents the concentration of each compound required to yield a positive reading. A lower cutoff indicates a greater ability to detect the compound.

Compound Synonyms / Brand Names / Common Names Cutoff
Methadone Methadon, Metadone, Metadona / Dolophine, Methadone Hydrochloride Intensol, Methadose / Dones 300
Doxylamine Doxylamin, Doxilamina / Bonjesta, Diclegis, NyQuil, Unisom 50,000

Methadone - Definition and Description

Methadone is a synthetic opioid, available in the United States only by prescription and for use by licensed medical facilities. Street methadone is commercially produced methadone that is either a diverted prescription or the subject of another form of diversion. Methadone is classified as a narcotic analgesic, found in the form of oral tablets, oral solutions, and injectable forms. Methadone acts in the brain as a full opioid agonist and is effective at curbing cravings and withdrawal symptoms in users who have developed physical dependence on opioids. While it can be prescribed for treating pain, methadone is better known for treating opioid use disorder (OUD), where it is used as a replacement drug during medication-assisted therapy (MAT). Similar to the opioids it is intended to replace, methadone is prone to abuse and is highly addictive, capable of producing harsh withdrawal symptoms when abstinence is attempted by users with physical dependence on methadone or other opioids. [1]

For more information, see: Methadone Facts and Information.

Summary - MTD Methadone Urine Test Panel

Methadone is the target compound for the MTD One Step Methadone Drug Test, detected at a cutoff level of 300 ng/mL. Methadone is indicated for treating opioid addiction/dependence and for treating pain. Methadone is found in the form of oral tablets, oral solutions, and injectable forms, dispensed under generic labels and the brands Dolophine, Methadone Hydrochloride Intensol, and Methadose. Following methadone use, approximately 5–50% is recovered in the urine as unchanged methadone, 2–25% as EDDP, and less than 1% as EMDP. These rates are significantly impacted by variations in urine pH, urine volume, dose, and rate of metabolism. In methadone maintenance subjects, urinary concentrations of methadone and EDDP ranging from 1,000–50,000 ng/mL are commonly encountered. [2]

Related Pages


Links for references open in a new tab or window.

  1. Rettig RA, Yarmolinsky A (Eds). (1995). "Federal Regulation of Methadone Treatment" (Ch 2: Pharmacology and Medical Aspects of Methadone Treatment). Washington, DC: National Academies Press. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK232112/, [PDF file]
  2. Baselt RC, Cravey RH. (1989). "Disposition of Toxic Drugs and Chemicals in Man" (3rd ed, pp 512–516). USA: Year Book Medical Publishers, Inc.

Last Revision: